IGCS Advocacy Committee Call for Involvement

Join the IGCS Advocacy Committee!

The International Gynecologic Cancer Society (IGCS) Advocacy Committee is excited to announce opportunities for new advisory members to join our global team of advocates, clinicians, and professionals. As an advisory (unpaid) role, committee members provide expertise and strategic input to guide IGCS’s global advocacy efforts, amplify survivor and caregiver voices, and help raise awareness of gynecologic cancers worldwide. As a preference, but not a necessity, we are particularly looking for those who are:

A professional with expertise in health policy and advocacy, with experience engaging policymakers, health systems, or international agencies, and/or
A professional with expertise in campaigns and awareness, with experience in health communications, advocacy campaigns, or public engagement.

Committee members contribute their knowledge, time, and networks to help shape impactful IGCS initiatives. This is a unique opportunity to collaborate with a global community and advance our mission to improve outcomes for women affected by gynecologic cancers. If you are passionate about global women’s health and advocacy, we invite you to express your interest in joining the IGCS Advocacy Committee.

Join the IGCS Advocacy Committee

Gynecologic Cancer Awareness Month

September is Gynecologic Cancer Awareness Month, a time to recognize the global burden of the five gynecologic cancers—cervical, ovarian, uterine, vaginal, and vulvar—and renew our collective commitment to improving outcomes for all who are affected. The International Gynecologic Cancer Society (IGCS) and the International Gynecologic Cancer Advocacy Network (IGCAN) are proud to represent a diverse, united community of clinicians, researchers, survivors, and advocates working together to raise awareness, expand access to care, and advance education.

In recognition of this important month, IGCS is proud to share special educational offerings and resources to support both the global medical community and the patients we serve.

Master Sessions from IGCS 2024 in Dublin

To advance learning and collaboration, IGCS is making available—for both members and non-members—the full recordings of the Master Sessions from the 2024 IGCS Annual Global Meeting. These sessions feature world-renowned experts and cutting-edge updates in gynecologic oncology.
Access them all through the IGCS Education360 Learning Portal.

Cervix: Moving Forwards

Ovary: The Era of Targeted Therapies

Endometrial: Changing the Landscape

Vulvar/Vaginal: State of Art

Open Access to September Issue of The International Gynecological Cancer Society

For the first time ever, the International Journal of Gynecological Cancer (IJGC) will make its entire September issue freely accessible online for the duration of the month. Thanks to the leadership of Dr. Pedro Ramirez, IJGC Editor-in-Chief, this initiative highlights the importance of knowledge-sharing in raising awareness—not just among the public, but also across the global medical and research community.

Explore the latest research, clinical insights, and expert perspectives in this special open-access issue.

Access IJGC September Issue

Informational Graphics from IGCS and IGCAN!

What is Gestational Trophoblastic Disease Cancer

Zoom Background from IGCS and IGCAN

Uterine Cancer Awareness

2024 Impact

Reducing Disparities in Uterine Cancer

A Global Call to Action

The 2024 Uterine Cancer Awareness Month Campaign intensifies the global call to action, drawing attention to the stark disparities in uterine cancer worldwide. In this newly released consensus statement, supported by dozens of patient advocacy groups from all regions of the world, together we communicate the need for advocacy and action.

Uterine cancer affects women of all backgrounds, but disparities persist in detecting and treating the disease based on race, ethnicity, income, region, and access to care. We are calling on organizations, individuals, and governments to help find solutions to:

Raise public awareness
Overcome barriers to diagnosis
Improve access to treatment
Support survivors
And Increase diversity in clinical research

The statement is also available in multiple languages, click here to learn more.

Lighting the Torch of Resilience

Inspired by the spirit of the 2024 Summer Olympics, watch and listen to these resilient women from around the world — women whose lives have been changed forever by a uterine cancer diagnosis. For far too long, uterine cancer has been overlooked. The women in this video understand that Uterine Cancer Awareness Month is an occasion for increased action and advocacy. In unison, they are calling for this disease to be recognized as a greater health priority, globally. They reject the stigma and taboo surrounding women’s reproductive health, call for increased efforts to educate the public about this disease, and boldly display how to turn a cancer diagnosis into advocacy.

This video is co-developed by IGCS and AstraZeneca with funding provided by AstraZeneca.

Participating Partners

Don't see your group listed? Join us! Contact IGCS Communications Specialist at debbie.leopold@igcs.org to find out how to join the network and let us know if you plan to recognize Uterine Cancer Awareness Month.

Uterine cancer is the most common gynecologic cancer among women residing in high-income countries.

And unlike many other cancers, the incidence and death rates are rising.

The number of deaths from this disease has been increasing by almost 2 percent each year, with even sharper spikes among Asian, Hispanic, and Black women in the United States.

Campaign Toolkit

Click here to download the campaign toolkit, including logos, images, and more for your own awareness campaign.

Below are examples of the materials you can find in our toolkit. We encourage individuals and advocacy groups to share these on social media throughout the month of June.

Want to translate the materials into other languages? We've created this helpful guide for translation and to access the image templates on Canva so you can edit them and even add your own logo. Have questions or need assistance? Email IGCS Communications Specialist at debbie.leopold@igcs.org.

2023 Launch video

Please include #UterineCancer on your social media posts so we can search for your posts and track the reach of this global campaign.

Available Education

Preventing the Most Common
Female Cancer Most Women
Have Never Heard Of

In this recorded lecture, Dr. Sarah Kitson, Gynae-Oncologist from the University of Manchester delves into the rising incidence of uterine (womb) cancer across the globe, particularly highlighting the regions of North America and Europe. She provides a thorough review of evidence linking factors such as hormonal aspects, obesity, and lifestyle with uterine cancer incidence, aiming to inform and educate about the challenges and necessary steps for better management and acceptable prevention strategies.

An Evolving Frontier - Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers

IGCS and Eisai welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to view the second presentation from the An Evolving Frontier - Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers Industry Supported Symposium presented at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.

IJGC Uterine Cancer Publications for UCAM 2024

A longitudinal study of sexual health and quality of life in endometrial carcinoma survivors
Amrita Datta et al.

Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
Luigi Antonio De Vitis et al.

Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
Bruna Tirapelli Goncalves et al.

Evaluating the use of machine learning in endometrial cancer: a systematic review
Sabrina Piedimonte et al.

Evaluation of the one-step nucleic acid amplification method for rapid detection of lymph node metastases in endometrial cancer: prospective, multicenter, comparative study
Eleonora La Fera et al.

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
Haider Mahdi et al.

Gestational trophoblastic neoplasia: does centralization of care impact clinical management?
Cristina Mitric et al.

Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease
Ferron G et al.

Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes
Giorgia Dinoi et al.

Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes.
Hiroshi Yoshida et al.

Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy
Vito Andrea Capozzi et al.

Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework
Valentina Bruno et al.

Major determinants of survival in recurrent endometrial cancer—the role of secondary cytoreductive surgery: a multicenter study
Virginia Vargiu et al.

Mismatch repair status and surgical approach in apparent early-stage endometrial cancer
Rhett Morton et al.

Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England
Scott Goulden et al.

Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta-analysis
Antonio Raffone et al.

Prognostic factors in patients with endometrial cancer with isolated lymphatic recurrence
Ilaria Capasso et al.

Prognostic factors in patients with uterine sarcoma: the SARCUT study
Ignacio Zapardiel et al.

Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study
Cucinella G et al.

Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer
Franziska Siegenthaler et al.

Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis
Sarah Bell et al.

Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasia
Wang W et al.

Race and ethnicity reporting in endometrial cancer literature
Raimondo D, et al.

Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion
Amy Jamieson et al.

Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis
Vieira-Serna S et al.

Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis
Chen Nahshon et al.

The Womb Cancer Awareness Measure (WCAM): development of an instrument to assess public awareness of endometrial cancer
Olivia Jones et al.

Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis
Matteo Pavone et al.

Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features
Fulvio Borella et al.

Uterine transposition for fertility preservation in pelvic cancers
Ribeiro R et al.

Industry Support

2023 Press Release (PR Newswire)

2023 Impact Report

2025 Nursing Symposium

Nursing and Allied Health Virtual Symposium
September 19, 2025
8:00 PM – 10:15 PM UTC

Connect with gynecologic oncology nursing and allied health professionals from around the world for an engaging, solutions-focused program that empowers the vital role of nursing in gynecologic cancer care. This free symposium will feature a powerful patient story, survivorship issues in fertility, menopause, and genetics, and provide multidisciplinary insights into gynecologic oncology.

This live online symposium will allow you to participate in discussions, ask questions, and take away actionable strategies you can implement in your own practice.

For those unable to attend live, a recording will be made available on
IGCS Education360 Learning Portal.

Program Highlights:

Survivorship Issues: Fertility & Menopause – Hear a moving patient story, gain insight into fertility preservation and surrogacy options, and explore innovative nurse-led menopause care and research.
Genetics in Gynecologic Oncology – Learn the latest updates from a nursing perspective on integrating genetic insights into patient care.
The Multidisciplinary Relationship – Meet the diverse allied health team members who work to deliver comprehensive cancer care. A panel discussion will be held between a nurse, clinical nurse consultant, nurse practitioner, physician assistant, social worker, and a physician.
Open Forum & Q&A – Submit your questions during registration to have experts provide their insights on patient care. Topics may include but are not limited to complications, wound care, and survivorship needs.

View Program

Who Should Attend:
Oncology nurses, advanced practice providers, allied health professionals, and anyone passionate about advancing patient-centered gynecologic cancer care.

2025 Presidential Plenary Topic & Panelists

Dear IGCS Members and Friends,

As President of the International Gynecologic Cancer Society (IGCS), I am honored to announce the topic and panelists for this year’s Presidential Plenary. Held during the IGCS Annual Global Meeting, the Presidential Address and Plenary is a moment to spotlight a topic of critical global relevance—one that reflects the evolving challenges and opportunities in gynecologic oncology.

Presidential Plenary at IGCS 2025
Improving Access to Cancer Surgery: A Part of the IGCS Mission
Wednesday, November 5 | 4:15 PM – 5:30 PM
IGCS Annual Global Meeting, Cape Town

I believe that each IGCS President brings a unique lens to this moment, shaped by the region they represent and the issues they are most passionate about. One of the defining strengths of IGCS is the rich diversity of our global membership. From high-resource centers to under-resourced clinics, our members are united by a shared mission, but their realities can look vastly different. The Presidential Plenary serves as a platform to elevate these varied perspectives and bring attention to regionally informed solutions that can inspire global action.

This year I have chosen for this presidential plenary to focus on improving access to cancer surgery—a subject closely aligned with the IGCS mission and strategic pillar to advance equitable patient care. Hosting this plenary in South Africa adds a meaningful layer, offering the chance to reflect on surgical access both regionally and globally.

Why Surgical Access Matters

I wrote a Presidential Message that was released on Earth Day about how accessible cancer care and sustainable practices go hand in hand. Surgical access is a cornerstone of gynecologic cancer care, yet across low-, middle-, and even high-income countries, patients face major barriers to receiving timely, safe, and affordable procedures.

These inequities are not just a matter of geography or infrastructure—they are tied to broader issues of sustainability:

Social sustainability demands we address inequities in training, workforce distribution, and access to care.
Environmental sustainability calls on us to be mindful of ecological impact, especially in areas where surgical resources and waste systems are limited.
Economic sustainability urges us to build cost-effective, scalable solutions that don’t compromise quality.

Sustainability in cancer surgery is not a single-issue problem—it’s a global challenge that requires collaboration, creativity, and courage. Click here to learn more and read the Presidential Plenary description.

A Thought-Provoking Program with Global Experts

This year’s panel will bring together voices from across the globe—experts who are innovating and advocating for surgical access in underserved settings:

Prof. Greta Dreyer
South Africa

Presidential address and introduction: Access to care as part of our sustainability initiative

Prof. Salome Maswime
South Africa

Global surgery project: Improving access to all surgery

Dr. J.S. (Fanus) Dreyer
Scotland

Regional collaboration and centers of excellence: An alternative to developing local expertise for all countries

Dr. Alex Mutombo
Dem. Republic of Congo

Focused training: Cervical cancer training to improve access to life-saving Wertheim hysterectomy

Panel Discussion
A collective dialogue on the way forward for low- and middle-income countries (LMICs)

Add the Plenary to Your Schedule

This plenary is more than a session; it is a call to action. Whether you work in a high-resource hospital or a remote clinic, the principles of equity, affordability, and sustainability affect us all. I hope you will join us for this timely and vital conversation—together, we can work toward a future where every woman, everywhere, has access to the surgical care she needs.

With purpose and hope,

Prof. Greta Dreyer
President, IGCS

Multi-disciplinary IGCS Membership

Special Membership Offer for New Medical & Radiation Clinical Oncologist Members!

In our continued commitment to embracing the multidisciplinary team as an integral part of IGCS, we are excited to announce a special membership offer to radiation and clinical oncologists and medical oncologists to join IGCS and our global community. All new medical and radiation clinical oncologist members who join this year will receive free membership for the remainder of 2025 and a 50% discount on 2026 membership fee.

IGCS Members have the opportunity to gain access to a dynamic professional community, educational resources, global outreach programs, and opportunities to engage with peers from around the world. Complete Your Membership.

Member Benefits Include:

Access to Education360 Learning Portal

Discounted Meeting Registration to IGCS 2025

Access to the International Journal of Gynecological Cancer

Educational Resources like the IGCS Certificate Programs

To complete your membership, contact our membership engagement specialist
Ivana Koleva at ivana.koleva@igcs.org.

Insights on IGCS’ Identity: Board Members Weigh In

A Reflection from IGCS CEO, Mary Eiken

What does it mean to belong to the International Gynecologic Cancer Society? Who are we today, and where are we headed?

These are the questions I’ve been reflecting on—not only as CEO, but as someone who has had the privilege of working alongside countless clinicians, advocates, and global health champions who have built IGCS into what it is today. A global society that leverages its strategic pillars to continue to drive change. To help inform this reflection, I recently turned to our Board of Directors and staff and asked them to share their perspectives on the IGCS identity—what sets us apart, what inspires them, and what they believe our role should be in the future of gynecologic oncology.

Their responses were honest, passionate, and deeply unifying. One theme came through loud and clear: IGCS is operating at its best when our members—are empowered, connected, and leading the way.

A Society Rooted in Global Connection

One theme emerged loud and clear: IGCS is a truly global society—not just in name, but in action.

"IGCS is the only truly global organization in the field of gynecologic cancers."

With members in over 130 countries, our reach spans continents and cultures. What sets us apart is our commitment to equity—delivering education, mentorship, and resources to professionals in both high- and low-resource settings. As one board member put it:

"Education for young doctors and a global perspective that does not focus solely on advanced countries."

IGCS strives to be as inclusive as possible. From rotating our Annual Global Meeting across regions, to tailoring training programs like the Gynecologic Oncology Global Fellowship Program and monthly regional Project ECHO® virtual tumor board sessions, IGCS listens to what its members need and responds with purpose. Our most recent member benefit, multilingual closed captions available on Education360 Learning Portal is a testament to our commitment.

A Home for Mentorship, Growth, and Purpose

Many board members reflected on how they were first introduced to IGCS—often through a mentor, or a desire to grow professionally—and how that connection has deepened over time.

"I was able to meet colleagues from various countries around the world. Meeting IGCS and its colleagues motivated me to save patients from a global perspective. I have grown even more as a gynecologic oncologist."

Our members stay because IGCS is a home—a place where professional identity is not only supported, but shaped and strengthened. It’s a society where early-career clinicians find mentorship, where established leaders give back, and where friendships evolve into lifelong collaborations.

What IGCS Looks Like at Its Best

When asked what IGCS looks like when it’s operating at its best, the answers were as inspiring as they were consistent: a connected, vibrant, collaborative, and transformative global community.

“When IGCS is at its best, its impact is being felt simultaneously in multiple locations across the globe.”

“It should be a home—a place where your professional identity is determined and strengthened.”

“IGCS is a truly inclusive society that welcomes, connects, mentors, educates, advocates, and brings about positive change.”

That’s a powerful image—and one we strive to live up to every day.

The Heart of IGCS, in Their Words

We also asked our Board of Directors and staff to describe the tone and feeling they associate with IGCS. The words they shared tell the story of a society rooted in compassion, driven by purpose, and united by a bold, collective vision for change.

When grouped together, these words reveal four deeply interconnected themes that define who we are:

Compassion & Support – We lead with empathy, kindness, and connection.

Inclusivity & Equity – We welcome all voices and work to level the global playing field.

Collaboration & Community – We thrive on shared strength and mutual respect.

Inspiration & Innovation – We push boundaries, nurture ideas, and believe in the power of progress.

This is how your leadership team experiences IGCS—and how they want the world to experience it too. These aren’t just words. They’re touchstones for the culture we’ve built and the future we are shaping together.

A Path Forward, Together

We also asked our Board who they would introduce to IGCS. Their answers affirmed our mission: early-career professionals in under-resourced settings, retiring clinicians eager to give back, and multidisciplinary colleagues who haven’t yet found a home in a global network like ours.

“The talented young gynecologist working in rural Africa, Asia, or Latin America striving to make a difference.”

“The professor who wants to expand their educational impact beyond borders.”

“The oncologist nearing retirement who wants to give back.”

“Key members of the broader multidisciplinary team—such as pathology, radiation oncologists or nurses—who may not yet be deeply involved with IGCS but must feel welcomed.”

These are the people we serve—and the people who will carry IGCS into the future.

What This Means for You

If you’re already part of our community, I hope this gives you a sense of how invested our leadership is in strengthening and evolving IGCS. Your board is not only engaged—they are actively shaping the future of this organization with intention, insight, and a deep respect for our collective mission.

If you’re not yet a member, I hope you’ll consider joining us. There is a place for you here—whether you're a trainee in need of guidance, a researcher with global aspirations, a nurse on the front lines, or a thought leader seeking change.

Together, we are building something remarkable.

Learn in Your Language: Multilingual Captions Now Available on IGCS Education360

We’re thrilled to announce a major milestone in our mission to deliver equitable, inclusive education to gynecologic oncology professionals around the world.

Multilingual closed captions are now available across the IGCS Education360 Learning Portal. This new feature enables viewers to watch videos while reading translated subtitles in the language they understand best, making it easier than ever to access critical clinical knowledge.

This advancement directly supports IGCS Strategic Pillars Enhance Member and Guest Experience and Advancing Equitable Patient-Centered Care by cultivating an inclusive and diverse culture, enhancing the learning portal as a valuable member benefit, and expanding global access to high-quality gynecologic cancer educational resources.

Whether you're watching a video lecture, journal club, surgical film, or expert panel discussion, learning in your own language is now just a few clicks away.

At IGCS, we believe that education should have no language barriers. This is more than a technology update—it’s a powerful step forward in global access, inclusion, and impact.

How it works

The original spoken audio remains unchanged
Written captions are auto-generated with artificial intelligence.
Viewers can select from 12 available languages to read along in their preferred language

Languages available

Chinese ǀ Dutch ǀ English ǀ French ǀ German ǀ Indonesian ǀ Italian
Japanese ǀ Korean ǀ Portuguese ǀ Russian ǀ Spanish

How to use translated captions

Open a video in Education360 Learning Portal
Click the “CC” icon to enable closed captions
Select your preferred language from the list that appears.
Captions will automatically appear corresponding to the audio as the video plays

Not yet a member? Join IGCS to access our full library of educational content and experience the benefits of global learning.

Questions or missing your language? Contact us at education@igcs.org

2025 Dicey Scroggins Distinguished Advocate Award

IGCS 2025 Advocacy Award Recipients

The International Gynecologic Cancer Advocacy Network (IGCAN) and International Gynecologic Cancer Society (IGCS) are to announce the 2025 recipients of the Dicey Scroggins Distinguished Advocate Award, recognizing exceptional individuals and organizations whose work has made a lasting impact on gynecologic cancer advocacy and patient-centered care around the world.

Please join us in celebrating:

2025 Dicey Scroggins Distinguished Advocate Award
This award recognizes advocates and organizations that provide active, dedicated service to patients/survivors, families, and caregivers—on a local, regional, or international level—and persistently engage in the fight against gynecologic cancers.

Jonathan Ledermann

Eva-Maria Strömsholm (Finland) has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award, in recognition of her extraordinary commitment to gynecologic cancer advocacy and patient-centered care.

A survivor of dysgerminoma, a rare ovarian cancer diagnosed at just 27, Eva-Maria has transformed her personal experience into a lifelong mission to improve outcomes for women affected by gynecologic cancers—particularly those facing rare diagnoses. Her resilience and unwavering positivity have inspired patients, clinicians, and advocates around the world.

Eva-Maria brings both professional and personal insight to her advocacy, drawing on her experience as a nurse to inform her compassionate and practical approach. She actively collaborates with major international organizations, including the European Society of Gynaecological Oncology (ESGO/ENGAGe), the European Society of Medical Oncology (ESMO), the World Ovarian Cancer Coalition (WOCC), ERN EURACAN, WHO/IARC, and IGCS, among others.

Among her many contributions, Eva-Maria has played a key role in:

Co-founding the Finnish Association of Gynaecological Cancer Patients

Developing patient information leaflets for rare gynecologic cancers, now published by EURACAN.

Advancing the “Diagnosis Curator” model to support patients shortly after diagnosis.

Serving on numerous global working groups to improve cancer care and patient inclusion in research and policymaking.

She is also Chair of the Nordic Gynecological Cancer Patient Organisation Network (NGPO) and a respected voice for patients across Europe and beyond. In her home country of Finland, the jury of the Citizen’s Forum honored her with the title, “Volunteer of the Year” in 2022 for her voluntary work in the cancer field and for cancer patients.

Eva-Maria exemplifies the spirit of this award through her passion, leadership, and tireless efforts to ensure that all gynecologic cancer patients—no matter how rare their diagnosis—are heard, supported, and empowered.

Nefa-Tari Moore
United States

The International Gynecologic Cancer Society is proud to announce that Nefa-Tari Moore, Director of Black Women’s Outreach at SHARE Cancer Support, has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award.

A three-time uterine and ovarian cancer thriver, Licensed Practical Nurse, and tireless patient advocate, Ms. Moore has transformed her personal journey into a mission of empowerment, awareness, and systemic change. After finding hope and solidarity through a SHARE support group, she became an AfroSHARE Ambassador and later played a pivotal role in launching SHARE’s national Uterine Cancer Program—designed to center and support the voices of Black women, who are disproportionately affected by uterine cancer.

With a healthcare background and a lifelong commitment to community activism, Ms. Moore now leads impactful programs that educate, uplift, and connect people affected by gynecologic cancers. She has facilitated transformative peer-led groups and continues to amplify survivor perspectives through high-profile initiatives, including the Spot Her campaign and the first-ever AfroSHARE Summit held in June this year.

A nationally recognized patient expert and speaker, Ms. Moore has served on the National Cancer Institute’s Uterine Cancer Task Force and collaborates with major healthcare institutions and oncology forums worldwide to drive policy change and improve equity in cancer care.

With grace, empathy, and unwavering purpose, Nefa-Tari Moore exemplifies the legacy of Dicey Scroggins—bridging personal experience with public impact. Please join us in celebrating her achievements and the extraordinary contributions she continues to make to the gynecologic cancer community.

ISGOPPI The Irish Society of Gynaecological Oncology Public and Patient Involvement Group (ISGOPPI)
Ireland

The International Gynecologic Cancer Society is honored to announce that the Irish Society of Gynaecological Oncology Public and Patient Involvement group (ISGOPPI) has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award.

Led by visionary co-founders Dr. Sharon O’Toole and Yvonne O’Meara, ISGOPPI has become Ireland’s national leader in centering the patient voice within gynecologic cancer care, education, and research. The group operates under the umbrella of the Irish Society of Gynaecological Oncology (ISGO), a multidisciplinary society encompassing all gynecologic cancers. ISGOPPI has forged a strong, collaborative model for public and patient involvement that is transforming how ovarian, cervical, uterine, vaginal, and vulvar cancers are understood, experienced, and addressed.

Through groundbreaking initiatives such as the personalised platform thisisGO.ie, the collaborative OvaCare support and networking program, and nationwide awareness campaigns, ISGOPPI has built a powerful community of advocates, researchers, and survivors. Since its founding in 2016, the group has trained more than 100 patient partners in research methods, enabling true co-production of national policy, public education, and scientific discovery. Their work has contributed to earlier detection, better survivorship, and greater empowerment for women across Ireland and beyond.

ISGOPPI’s success is rooted in the passion and generosity of its members, their willingness to share their stories and expertise, and the dedication of healthcare professionals committed to improving outcomes through partnership. The legacy of this group—and of Sharon and Yvonne’s leadership—is perhaps best measured in the lives they’ve touched: from individual patients finding community and strength, to national health systems shaped by survivor voices, to international collaborations inspired by their inclusive approach.

Through compassion, collaboration, and a commitment to equity, ISGOPPI truly embodies the spirit of Dicey Scroggins. We are proud to recognize their extraordinary contributions to gynecologic cancer advocacy.

Please join us in celebrating this year’s award recipients. They will be recognized in a ceremony during the 2025 IGCAN Advocacy Summit, which will be held virtually on September 27, 2025.

With gratitude,

Rosalind Glasspool, MD (UK)
IGCS Advocacy Committee Chair
Medical Oncologist, University of Glasgow
NHS Greater Glasgow and Clyde

Abhishek Shankar, MD (India)
IGCS Advocacy Committee Vice Chair
Assistant Professor, Radiation Oncology
AIIMS, Delhi

2025 Awards

IGCS 2025 Award Recipients

We are pleased to announce the recipients of the International Gynecologic Cancer Society’s 2025 Organizational Awards.

Their international recognition not only honors the dedication and innovation of these outstanding IGCS Members but also inspires all of us to continue driving change and pursue excellence. Please join us in celebrating the achievements and contributions of these inspiring members. Through their example, we reinforce our shared commitment to equity, excellence, and the advancement of gynecologic cancer care worldwide.

2025 IGCS LIFETIME ACHIEVEMENT AWARD
Honoring a career of exceptional contributions to gynecologic oncology through research, leadership, mentorship, and collaboration.

Jonathan Ledermann, BSc, MD, FRCP, FMedSci
UCL Cancer Institute, UK

Dr. Jonathan Ledermann is the recipient of the 2025 IGCS Lifetime Achievement Award, honoring his decades of extraordinary contributions to the field of gynecologic oncology through research, clinical leadership, mentorship, and international collaboration.

A renowned researcher and Professor of Medical Oncology at the UCL Cancer Institute, University College London, Dr. Ledermann has dedicated more than 30 years to advancing the treatment and understanding of gynecologic cancers. His clinical and academic work has driven significant improvements in care—particularly the use of PARP inhibitors for women with homologous recombination deficient ovarian cancers—through practice-changing clinical trials and a relentless commitment to evidence-based innovation.

As a founding member of ENGOT, former Director of the Cancer Research UK & UCL Cancer Trials Centre, and a Senior Investigator for the National Institute of Health Research (NIHR), Dr. Ledermann has built a legacy of leadership in cancer research, driving progress in the treatment of ovarian and cervical cancers. Under his guidance, the Cancer Trials Centre became one of the leading national and international hubs for gynecologic cancer clinical trials, shaping treatment guidelines and improving outcomes for women around the world.

Dr. Ledermann’s influence extends far beyond the lab and clinic. He has served in numerous leadership roles in the global gynecologic cancer community, including as:

Council Member of the International Gynecologic Cancer Society (IGCS)
Vice President of the European Society of Gynaecological Oncology (ESGO)
Chair of the NCRI UK Gynaecological Cancer Trials Group
Chair of the Rare Tumor Working Group within the Gynecologic Cancer InterGroup (GCIG)
Chair or Group leader of Consensus Conferences and Guidelines Committees on behalf of ESMO and ESGO
Subject Editor for ESMO Gynaecological Cancer Practice Guidelines

In addition to his many honors and affiliations, he is a Fellow of the UK Academy of Medical Sciences, a widely respected editor and author with more than 320 published papers. His clear, compassionate voice has been heard at countless scientific meetings worldwide, where he continues to inspire the next generation of clinicians and researchers.

Dr. Ledermann gained his degree in medicine at University College London and trained in internal medicine and oncology in London and then in Toronto, receiving his Doctorate in Medicine in 1990 and becoming a Fellow of the Royal College of Physicians in 1993. His impact as a mentor, educator, and leader has touched institutions and individuals across the globe, making him a true champion of progress in gynecologic oncology.

The IGCS Lifetime Achievement Award is presented to individuals who have made significant and lasting contributions to the field over the course of their careers. Dr. Ledermann exemplifies this legacy through a career marked by visionary leadership, unwavering dedication, and a profound commitment to improving the lives of women affected by gynecologic cancers.

2025 IGCS Award for Outstanding Achievement in Gynecologic Oncology Surgery
Recognizes gynecologic oncologists who have had a sustained career in academic surgery and have made seminal contributions in clinical surgery or surgical education that established new benchmarks or paradigms.

Reitan Ribeiro, MD
McGill University Health Center Surgery, Canada

Dr. Reitan Ribeiro is internationally recognized for developing the uterine transposition technique—a surgical procedure that involves temporarily moving the uterus and ovaries to a different location in the abdomen, typically out of the pelvis, to protect them from the damaging effects of pelvic radiation therapy. This groundbreaking fertility-preserving procedure has transformed care for women undergoing pelvic radiation therapy and is now practiced around the world.

In addition to pioneering advancements in minimally invasive surgery, Dr. Ribeiro has contributed to influential clinical trials, including LACC, Alice, Keynote 001, SGNTV-003, and others. His dedication to surgical education and global mentorship continues to shape the next generation of gynecologic oncologists.

Through his unwavering commitment to surgical innovation, clinical research, and surgical education, Dr. Ribeiro has set new benchmarks and paradigms that will continue to shape gynecologic oncology for generations to come. His work has left a lasting impact on both patient care and the development of future surgeons, making him a truly deserving candidate for this prestigious international award.

He has received several prestigious awards, including an Honorable Mention from the Chamber of Deputies of Paraná, Brazil, and the National Medical Treatment Innovation Award (VEJA). His innovative work has also earned him the best video award from the Society of Gynecologic Oncology (SGO), further cementing his status as a thought leader in the field.

Dr. Ribeiro completed his medical degree at the Federal University of Porto Alegre (Brazil) and pursued his General Surgery residency at Celso Ramos Hospital and Surgical Oncology residency at Erasto Gaertner Hospital, both in Brazil. He specialized in Gynecologic Oncology at Erasto Gaertner Hospital, where he later became the Research Director of the Gynecologic Oncology Division. Dr. Ribeiro is currently an Assistant Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. He is an attending Gynecologic Oncologist and Surgical Oncologist at the Cedars Cancer Center, McGill University Health Center, where he practices as both a clinician and scientist.

2025 IGCS Global Humanitarian Award
Recognizes outstanding individuals, organizations, or programs who work to improve access to quality gynecologic oncology services in low- to middle-income countries or in areas of need within more developed nations.

Barry Rosen, MD and Allan Covens, MD, FRCSC
University of Toronto, Canada

Dr. Barry Rosen and Dr. Allan Covens have been selected as the recipients of the 2025 IGCS Global Humanitarian Award, recognizing their outstanding commitment to global mentorship and their transformative contributions to gynecologic oncology training in low-resource settings.

Since 2008, Drs. Rosen and Covens have been deeply involved in building and leading the gynecologic oncology training program at Moi University in Eldoret, Kenya, as part of the AMPATH consortium led by Indiana University. Their work has not only strengthened cancer care in Kenya but also served as a catalyst for the creation and expansion of the IGCS Global Gynecologic Oncology Fellowship Program.

When IGCS launched the Global Fellowship Program in 2017, the foundational model and mentorship structure developed by Drs. Rosen and Covens in Kenya provided a blueprint for success. Their willingness to integrate the Moi fellowship into this new global initiative, along with their guidance and support, helped shape what has become one of IGCS’s most impactful programs.

Today, the IGCS Global Gynecologic Oncology Fellowship Program has grown to include 22 training sites, supported by hundreds of volunteer mentors, with over 50 fellows trained—many of whom are now leaders in their own countries or neighboring nations. This extraordinary global reach can be traced back in part to the vision and leadership of Drs. Rosen and Covens.

In Kenya, they have trained local gynecologic oncology surgeons, launched cervical cancer screening programs, and supported research and publication efforts. Their work has been recognized by the Kenyan Medical and Dental Council, and their trainees are now actively delivering skilled care across the region.

Dr. Barry Rosen, former Head of Gynecologic Oncology at the University of Toronto, has brought his expertise in prevention and hereditary cancer to the international stage, advancing care for women across both high- and low-resource settings.

Dr. Allan Covens, Professor and former Chair of the Division of Gynecologic Oncology at the University of Toronto and Sunnybrook Health Sciences Centre, serves as Chair of the IGCS Examination Committee, ensuring academic excellence across all fellowship sites. He continues to provide weekly virtual teaching sessions for fellows in Kenya.

Together, their unwavering commitment to mentorship, collaboration, and sustainable capacity-building reflects the true spirit of the IGCS Global Humanitarian Award.

2025 IGCS Excellence in Teaching Award
Recognizes individuals deeply committed to the profession whose work and accomplishments set a standard of excellence. This award recognizes the importance of teaching as an integral part of women’s cancer care and the lasting impact of educators to shape and inspire future generations of clinicians and researchers.

Sarikapan Wilailak, MD
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand

Professor Sarikapan Wilailak is the recipient of the 2025 IGCS Excellence in Teaching Award.

An Emeritus Professor and trailblazer in Thai gynecologic oncology, Prof. Wilailak has spent her distinguished career inspiring and educating generations of medical professionals. Known for her clarity, compassion, and deep commitment to teaching, she has mentored students, residents, and fellows with patience and purpose—transforming complex oncologic concepts into accessible, engaging learning experiences.

Her pioneering efforts include founding Thailand’s first tumor registry and biobank, advancing laparoscopic surgery training through international workshops, and establishing inclusive learning opportunities across institutions nationwide. As a leader, she has held key roles including Chair of Department, Deputy Dean for Academic Affairs, and President of the Royal Thai College of Obstetricians and Gynecologists, shaping national and regional education policy.

Prof. Wilailak’s international influence spans roles with ASGO, AOFOG, and FIGO, where she has championed global educational collaborations in women’s cancer care.

She embodies the spirit of this award—educator, innovator, and role model—and we are honored to recognize her incredible contributions to advance the field of gynecologic oncology.

Her impact as an educator is both far-reaching and deeply personal—she has not only advanced the field but also elevated those around her through her thoughtful, empowering approach to teaching. Her work reflects the highest standards of excellence, and its impact will only continue to grow through her students and mentees. We are honored to recognize her remarkable contributions with the 2025 IGCS Excellence in Teaching Award.

Mario M. Leitao, Jr., MD, FACOG, FACS
Memorial Sloan Kettering Cancer Center, USA

Dr. Mario Leitao is recognized with the 2025 IGCS Excellence in Teaching Award for his outstanding leadership, mentorship, and unwavering commitment to surgical education in gynecologic oncology.

A U.S. board-certified gynecologic oncologist, Dr. Leitao serves as a Member and Attending Surgeon in the Division of Gynecology at Memorial Sloan Kettering Cancer Center (MSKCC) and as a Professor of Obstetrics and Gynecology at Weill Cornell Medical College. He is also the Director of the Gynecologic Oncology Fellowship Program at MSKCC—one of the largest and most comprehensive fellowships in the world, training 14 clinical fellows and 3 research fellows annually, including a longstanding and continuously active International Training Program, the only one in the U.S. with ESGO accreditation.

In addition, Dr. Leitao leads the Minimal Access and Robotic Surgery (MARS) Program at MSKCC, overseeing minimally invasive surgical training across multiple disciplines. He is globally respected for pioneering surgical techniques, having authored over 270 peer-reviewed publications, more than 80 reviews and textbook chapters, and co-editing a leading surgical textbook.

Throughout his career, Dr. Leitao has shared his expertise around the world—delivering lectures, performing live surgeries, and supporting the development of robotic and minimally invasive programs across continents. His deep commitment to global education is reflected in his service to IGCS, including roles as North America Representative on the Board of Directors and current Chair of the IGCS Minimal Access Surgery Training Program.

Dr. Leitao’s tireless mentorship, global impact, and scholarly contributions have shaped generations of gynecologic oncologists. His approach to teaching—rooted in generosity, precision, and the relentless pursuit of excellence—is what defines a truly great educator. Please join us in celebrating his remarkable achievements and well-deserved recognition.

View Past Award Recipients

Earlier this year, in March and April, we invited our membership to submit nominations recognizing individuals and organizations for their outstanding contributions to gynecologic oncology. All nominations were carefully reviewed by the IGCS Nominations and Awards Committee, with final selections made by the IGCS Board of Directors.

We extend our sincere thanks to everyone who submitted a nomination. The quality and breadth of the submissions were truly remarkable, making the deliberations both inspiring and challenging. The number of deserving candidates is a testament to the strength and dedication of our global community.

We are honored to recognize this year’s awardees for their exceptional contributions to advancing care, research, and education in our field. We plan to open award nominations for the 2026 cycle soon. Stay tuned for more information.

Respectfully,

Keiichi Fujiwara, MD, PhD
IGCS Nominations and Awards Committee Chair
IGCS Immediate Past President

At the close of the 2025 Award Nomination period, IGCS will transition to a year-long nomination process. Award Nominations for 2026 will open later this year.